Invention Grant
- Patent Title: Highly concentrated anti-CD40 antibody pharmaceutical preparation
- Patent Title (中): 高度集中的抗CD40抗体药物制剂
-
Application No.: US14000103Application Date: 2012-02-16
-
Publication No.: US09125893B2Publication Date: 2015-09-08
- Inventor: Ryosuke Endo , Tomoyoshi Ishikawa , Hiroyuki Suetomo
- Applicant: Ryosuke Endo , Tomoyoshi Ishikawa , Hiroyuki Suetomo
- Applicant Address: JP Tokyo
- Assignee: Kyowa Hakko Kirin Co., Ltd.
- Current Assignee: Kyowa Hakko Kirin Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Foley & Lardner LLP
- Priority: JP2011-031894 20110217
- International Application: PCT/JP2012/053687 WO 20120216
- International Announcement: WO2012/111762 WO 20120823
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K9/08 ; A61K47/18
Abstract:
The present invention relates to a highly concentrated solution preparation of antagonistic anti-CD40 antibody, in which occurrence of turbidity or insoluble foreign matter attributed to antibodies is suppressed to a level equivalent to that of the conventional low-concentration lyophilized preparation.
Public/Granted literature
- US20130323267A1 HIGHLY CONCENTRATED ANTI-CD40 ANTIBODY PHARMACEUTICAL PREPARATION Public/Granted day:2013-12-05
Information query
